Alan Auerbach
Chief Executive Officer presso PUMA BIOTECHNOLOGY, INC.
Patrimonio netto: 44 M $ in data 29/02/2024
Profilo
Alan H.
Auerbach founded Cougar Biotechnology, Inc. and Puma Biotechnology, Inc. He occupies the position of Chairman, President & Chief Executive Officer for Puma Biotechnology, Inc.
In his past career he occupied the position of Vice President of Seidler Cos., Inc., Chairman, President & Chief Executive Officer at Innovative Acquisitions Corp., President, Chief Executive Officer & Director at Cougar Biotechnology, Inc., Vice President & Senior Research Analyst at Diagnostic Products Corp.
and Vice President & Senior Research Analyst at Wells Fargo Securities (Old).
Alan H.
Auerbach received an undergraduate degree from Boston University and a graduate degree from the University of Southern California.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
14.93% | 15/03/2024 | 7 104 320 ( 14.93% ) | 44 M $ | 29/02/2024 |
Posizioni attive di Alan Auerbach
Società | Posizione | Inizio |
---|---|---|
PUMA BIOTECHNOLOGY, INC. | Chief Executive Officer | 01/10/2011 |
Precedenti posizioni note di Alan Auerbach
Società | Posizione | Fine |
---|---|---|
RADIUS HEALTH, INC. | Director/Board Member | 29/12/2017 |
Innovative Acquisitions Corp.
Innovative Acquisitions Corp. Financial ConglomeratesFinance Innovative Acquisitions Corp. operates as a blank check company. It engages in organizational efforts and obtaining initial financing. The firm intends to acquire or merge with an existing company. The company was founded on April 27, 2007 and is headquartered in Cumberland, RI. | Chairman | 09/12/2011 |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Founder | 13/07/2009 |
Wells Fargo Securities (Old) | Analyst-Equity | 01/04/2003 |
Seidler Cos., Inc. | Corporate Officer/Principal | 01/05/1998 |
Formazione di Alan Auerbach
Boston University | Undergraduate Degree |
University of Southern California | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PUMA BIOTECHNOLOGY, INC. | Health Technology |
Aziende private | 6 |
---|---|
Diagnostic Products Corp.
Diagnostic Products Corp. Medical SpecialtiesHealth Technology Diagnostic Products Corp. provides immunodiagnostic systems, which includes IMMULITE series of immunoassay systems, more than 75 immunoassays. It also designs and manufactures automated laboratory instrumentation and automation solutions. Diagnostic Products is located in Los Angeles, CA. | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
Innovative Acquisitions Corp.
Innovative Acquisitions Corp. Financial ConglomeratesFinance Innovative Acquisitions Corp. operates as a blank check company. It engages in organizational efforts and obtaining initial financing. The firm intends to acquire or merge with an existing company. The company was founded on April 27, 2007 and is headquartered in Cumberland, RI. | Finance |
Wells Fargo Securities (Old) | Finance |
Seidler Cos., Inc. | Finance |